The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter, randomized phase II study of neoadjuvant pembrolizumab plus chemotherapy and chemoradiotherapy in esophageal adenocarcinoma (EAC).
 
Manish A. Shah
Consulting or Advisory Role - Astellas Pharma; Lilly Japan
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Oncolys BioPharma (Inst)
 
Khaldoun Almhanna
Consulting or Advisory Role - Merck; QED Therapeutics
Speakers' Bureau - Eisai
 
Syma Iqbal
Honoraria - AstraZeneca; Celgene; Eisai
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - Celgene
 
Prashant Thakkar
No Relationships to Disclose
 
Bryan J. Schneider
Research Funding - Merck
 
Rhonda Yantiss
No Relationships to Disclose
 
Yiru Wu
No Relationships to Disclose
 
Emma Futamura
No Relationships to Disclose
 
Jeffrey L. Port
Leadership - Angiocrine Bioscience; TMRW Life Sciences; View Point Medical
Stock and Other Ownership Interests - Angiocrine Bioscience; TMRW Life Sciences; View Point Medical
 
Cathy Spinelli
Employment - Novartis (I)
 
Sandipto Sarkar
No Relationships to Disclose
 
Paul J. Christos
No Relationships to Disclose
 
Gagandeep Brar
No Relationships to Disclose
 
Doron Betel
No Relationships to Disclose
 
Nicholas J. Sanfilippo
Stock and Other Ownership Interests - Oncodisc
 
Nasser K. Altorki
Stock and Other Ownership Interests - Angiocrine Bioscience; tomorrow; View Point Medical
Honoraria - AstraZeneca; Regeneron
Research Funding - AstraZeneca (Inst); Janssen Research & Development (Inst)